Waleed S. Koko

2 months ago | mdpi.com | Jingyi Ma |Tariq Khan |Waleed S. Koko |Imen Ben Abdelmalek

All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.

Nov 22, 2024 | mdpi.com | Waleed S. Koko |Tariq Khan |Rainer Schobert |Bernhard Biersack

1. IntroductionThe search for efficient and well-tolerated drugs for the therapy of perilous infectious diseases is ongoing. The apicomplexan parasite agent of toxoplasmosis, Toxoplasma gondii, occurs globally and poses a considerable health risk to vulnerable immunocompromised persons, such as people with HIV, organ transplant patients, and neonates [1,2,3].

Sep 19, 2023 | mdpi.com | Waleed S. Koko |Tariq Khan |Rainer Schobert |Bernhard Biersack

Open AccessArticle by 1,2, 2, 3, 4 and 4,* 1 Department of Biology, College of Science and Arts, Qassim University, Unaizah 51911, Saudi Arabia 2 Department of Science Laboratories, College of Science and Arts, Qassim University, Ar Rass 51921, Saudi Arabia 3 Department of Clinical Nutrition, College of Applied Health Sciences, Qassim University, Ar Rass 51921, Saudi Arabia 4 Organic Chemistry Laboratory, University Bayreuth, Universitätsstrasse 30, 95440 Bayreuth, Germany * Author to whom...